Sino Medical Sciences Technology Inc. (SHA:688108)
23.89
-0.15 (-0.62%)
At close: Jan 23, 2026
SHA:688108 Revenue
Sino Medical Sciences Technology had revenue of 123.38M CNY in the quarter ending September 30, 2025, with 17.73% growth. This brings the company's revenue in the last twelve months to 504.11M, up 20.85% year-over-year. In the year 2024, Sino Medical Sciences Technology had annual revenue of 458.74M with 33.64% growth.
Revenue (ttm)
504.11M
Revenue Growth
+20.85%
P/S Ratio
19.81
Revenue / Employee
729.53K
Employees
691
Market Cap
9.98B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 458.74M | 115.48M | 33.64% |
| Dec 31, 2023 | 343.26M | 150.40M | 77.99% |
| Dec 31, 2022 | 192.85M | -1.50M | -0.77% |
| Dec 31, 2021 | 194.36M | -133.06M | -40.64% |
| Dec 31, 2020 | 327.42M | -108.49M | -24.89% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shinva Medical Instrument | 9.58B |
| Sinocare | 4.71B |
| Cofoe Medical Technology | 3.13B |
| Guangzhou Wondfo Biotech Co.,Ltd | 2.57B |
| Qingdao Haier Biomedical Co.,Ltd | 2.26B |
| Edan Instruments | 1.90B |
| INKON Life Technology | 1.69B |
| Beijing Wandong Medical Technology | 1.62B |